DCT

1:23-cv-00554

Genzyme Corp v. Novartis Gene Therapies Inc

General
Filed
05/19/23
Cause of ActionPatent Infringement
SectorBiotech
StatusClosed
Patent Owner
Operating Company
Nature of Suit830 Patent
Judge
Period
PO Win Rate
--
36%